COPD Health Center
Latest Headlines
![](https://webarchive.library.unt.edu/web/20110512112505im_/http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/articles/thumbnails_daily_images/2011/03_2011/69x75_spiriva_vs_serevent_02.jpg)
Study: Spiriva Beats Serevent for COPD Flare-ups
Once-daily Spiriva (tiotropium) may be more effective at reducing risk for exacerbations among people with moderate to severe chronic obstructive pulmonary disease (COPD) than Serevent (salmeterol), a new study shows.
Once-daily Spiriva (tiotropium) may be more effective at reducing risk for exacerbations among people with moderate to severe chronic obstructive pulmonary disease (COPD) than Serevent (salmeterol), a new study shows.